Back to
CAPITAL FUND MANAGEMENT S.A.
ARWR
Showing 6 of 24 quarters
Position history for
CAPITAL FUND MANAGEMENT S.A.'s holdings in ARROWHEAD PHARMACEUTICALS IN
No. Capital Fund Management exited its ARWR (Arrowhead Pharmaceuticals in) position in Q4 2025. Its Q3 2025 13F listed 35,140 shares worth $1.2M. Capital Fund Management first reported ARWR in Q1 2019 and held it in 18 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$793,860
Total Shares Change
-40,984
Quarter-by-Quarter History